Back
Extreme Networks, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
35
EXTR
Extreme Networks, Inc.
Last Price:
$16.91
Seasonality Move:
-4.77%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$36.08
Seasonality Move:
-22.7%
Sell
35
Extreme Networks, Inc. (EXTR)
is a Sell
Is Extreme Networks, Inc. a Buy, Sell or Hold?
-
The current Extreme Networks, Inc. [EXTR] share price is $16.92. The Score for EXTR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
EXTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $36.05. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXTR Stock Price Chart
What is Extreme Networks, Inc.'s stock price today?
-
The Extreme Networks, Inc. share price today is $16.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $36.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight buying pressure.
EXTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 42.93 | Sell |
| Chaikin Money Flow: | 749055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.8 - 17.66) | Sell |
| Bollinger Bands (100): | (17.56 - 21.4) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.11 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 30003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.49 - 35.13) | Buy |
| Bollinger Bands (100): | (10.87 - 25.69) | Buy |
EXTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.83 | Buy |
| 20-day SMA: | 17.19 | Sell |
| 50-day SMA: | 17.96 | Sell |
| 200-day SMA: | 17.51 | Sell |
| 8-day EMA: | 16.91 | Buy |
| 20-day EMA: | 17.14 | Sell |
| 50-day EMA: | 17.87 | Sell |
| 200-day EMA: | 17.86 | Sell |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.28 | Buy |
| 20-day SMA: | 31 | Buy |
| 50-day SMA: | 23.25 | Buy |
| 200-day SMA: | 13.99 | Buy |
| 8-day EMA: | 35.25 | Buy |
| 20-day EMA: | 31.52 | Buy |
| 50-day EMA: | 25.41 | Buy |
| 200-day EMA: | 18.18 | Buy |
Extreme Networks, Inc. Earnings Growth & EXTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.20 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Extreme Networks, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||